Australia's Tetratherix jumps 15% on ASX debut

Shares of Australia's Tetratherix TTX.AX rise as much as 15.3% to A$3.320 on trading debut, compared with their IPO offer price of A$2.88 per share

Firm lists on the ASX to accelerate development of its polymer platform technology, Tetramatrix

Co raised A$25 million ($16.33 million) in its IPO, valuing it at A$145 million

TTX has developed a proprietary fluid matrix that is invisible to the body and does not induce any foreign bodily reaction to evolve regenerative medicine and targeted therapeutic delivery

TTX shares pare early surge to climb 0.7% at A$2.90, compared with 0.4% gain in the ASX200 benchmark index .AXJO